As of August 28, 2026, Nektar Therapeutics (NKTR) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Nektar Therapeutics has a market capitalization of $2.19B, 34.14M shares outstanding, 209 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $250.00M, 293.1K outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 39%
💰 Capital Raise
model 73%
• Critical: only 2.4 months cash remaining
• Active ATM program with $250M remaining capacity
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$2.19B
Shares Outstanding34.14M
Float21.31M
Cash$39.27M
Debt$133.50M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 58.2% shares (2026Q1 vs prior)
209 institutional holders · 31.43M shares
#1
FMR LLC
4.30M shares
#2
BVF INC/IL
2.56M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
2.39M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest6.30M
Days to Cover8.6
% of Float29.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2011-12-31
424B5
ATM
2026-04-20
4
INSIDER TRANSACTION
2026-02-20
4
INSIDER TRANSACTION
2026-02-20
424B5
ATM
2026-02-13
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual NKTR Dilution Snapshot
Nektar Therapeutics (NKTR) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $250.0M.
- Stored outstanding warrants: 293,103.
- Recent SEC activity tracked for NKTR: 424B5 on 2026-04-20; 4 on 2026-02-20; 4 on 2026-02-20.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track NKTR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NKTR — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for NKTR
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.